Table 3.

Subgroup analysis for the association between lumbar BMD and sarcopenia

Subgroup	Sarcopenia [OR(95%CI)]	P for interaction
Sex		0.0730
Man	0.15(0.04,0.56)
Female	0.02(0.00,0.11)
BMI		0.0594
< 25	0.29(0.01,5.84)
25–29.9	0.01(0.00,0.07)
≥ 30	0.12(0.03,0.44)
Year		0.1438
< 30	0.02(0.00,0.51)
30–39	0.01(0.00,0.18)
40–49	0.04(0.01,0.30)
≥ 50	0.25(0.06,1.12)
Hypertension		0.0647
Yes	0.25(0.05,1.24)
No	0.04(0.01,0.13)
Diabetes		0.1011
Yes	0.48(0.03,6.92)
No	0.04(0.01,0.13)
Smoking status		0.1287
Yes	0.15(0.04,0.62)
No	0.03(0.01,0.13)
Alcohol status		0.0391
Yes	0.61(0.06,5.86)
No	0.04(0.01,0.13)
Total cholesterol		0.8709
< 200	0.07(0.02,0.28)
≥ 200	0.06(0.01,0.27)
Triglycerides		0.2159
< 150	0.04(0.01,0.15)
≥ 150	0.17(0.03,1.06)
HDL-C		0.7099
< 40	0.04(0.00,0.38)
≥ 40	0.07(0.02,0.21)
LDL-C		0.5268
< 130	0.05(0.01,0.19)
≥ 130	0.10(0.02,0.49)

The results of subgroup analysis were adjusted for all covariates except effect modifier. BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol